20 February 2019 – contingency planning for no-deal Brexit
The designer and manufacturer of innovative technology for minimally invasive surgery, has updated the market on contingency planning for the possibility of the UK leaving the EU without an appropriate Withdrawal Agreement. On 15 February BSI Netherlands confirmed the successful reassignment of all of the company’s product certification from BSI Notified Body 0086 (U.K.) to the Netherlands Notified Body 2797. This is aimed at reassuring distribution partners and end users that there will be no disruption in the coming months. We rate the shares as a BUY.